Effects of Circuit Training Combine With Square-Stepping Exercise, Strength Training and Balance Training on Senior Fitness and Fall Risk in Elderly in the Community
Launched by HSIN-CHING, TSAI · Apr 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a special exercise program designed to help older adults improve their fitness and reduce their risk of falling. The program combines different types of exercises, including Square-Stepping, strength training, and balance training, all structured in a circuit format. It aims to see if this combination can enhance physical fitness, balance, and even mental sharpness while lowering the fear of falling and the actual rate of falls among seniors in the community.
To participate, individuals need to be 60 years or older, demonstrate normal mobility, and be cleared for exercise through a simple health questionnaire. The trial will involve 12 weeks of exercise sessions, held twice a week for 90 minutes each time. Participants will be placed into either the exercise group, which will follow the new program, or a control group, which will continue their usual activities. This study hopes to gather valuable information about how these exercises can benefit older adults and help them stay safe and active.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 60 years or older.
- • 2. Determine no exercise risk via ACSM's PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone).
- • 3. SPPB (Short Physical Performance Battery) score of 10 or above indicates normal mobility.
- • 4. Will not participate in other physical exercise programs after starting this program.
- Exclusion Criteria:
- • 1. Those who are unable to complete the assessment process (due to hearing, vision, etc.) or participate due to limited mobility problems.
- • 2. Those whose cognitive function cannot cooperate with the assessment process.
- • 3. Those whose attendance rate is less than 80%.
About Hsin Ching, Tsai
Hsin-Ching Tsai is a distinguished clinical trial sponsor known for its commitment to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, the organization emphasizes rigorous study design, ethical standards, and patient safety. Hsin-Ching Tsai collaborates with leading research institutions and healthcare professionals to facilitate clinical trials that aim to address unmet medical needs across various therapeutic areas. Their dedication to scientific excellence and adherence to regulatory compliance positions them as a trusted partner in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported